Abstract
We measured the effects of combinations of verapamil, vinblastine, mefloquine, and tamoxifen, all being modulators of the multidrug resistance pump, P-glycoprotein, on the accumulation of labelled daunomycin into multidrug-resistant -388 leukemia cells at 37°C. We found that, contrary to our initial expectations (based on Ayesh, Shao and Stein (1996) Biochim. Biophys. Acta 1316, 8), vinblastine, mefloquine, and tamoxifen all appeared to interact with one another synergistically, i.e. by the kinetics of a non-competitive interaction. A simple kinetic analysis showed that pairs of co-operating modulators can give apparent non-competitive behaviour, but refined kinetic analysis enables the two types of interaction to be distinguished. The modulators vinblastine, mefloquine, and tamoxifen thus appear to co-operate with one another in pairs to bring about reversal of β-glycoprotein. This may have important implications for the design of new modulators of P-glycoprotein.
| Original language | English |
|---|---|
| Pages (from-to) | 30-38 |
| Number of pages | 9 |
| Journal | Biochimica et Biophysica Acta - Molecular Basis of Disease |
| Volume | 1360 |
| Issue number | 1 |
| DOIs | |
| State | Published - 27 Feb 1997 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Behavior, non-competitive
- Cooperativity
- Kinetics
- Modulator
- Multidrug resistance
- P-glycoprotein
Fingerprint
Dive into the research topics of 'Mutually co-operative interactions between modulators of p-glycoprotein'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver